nodes	percent_of_prediction	percent_of_DWPC	metapath
Methacholine—Cholinergic syndrome—Irinotecan—pancreatic cancer	0.165	0.254	CcSEcCtD
Methacholine—Throat irritation—Tamoxifen—pancreatic cancer	0.0387	0.0594	CcSEcCtD
Methacholine—Chest tightness—Docetaxel—pancreatic cancer	0.0203	0.0312	CcSEcCtD
Methacholine—Lightheadedness—Tamoxifen—pancreatic cancer	0.0175	0.0268	CcSEcCtD
Methacholine—Retrosternal pain—Epirubicin—pancreatic cancer	0.0159	0.0245	CcSEcCtD
Methacholine—Retrosternal pain—Doxorubicin—pancreatic cancer	0.0148	0.0227	CcSEcCtD
Methacholine—Chest discomfort—Docetaxel—pancreatic cancer	0.0108	0.0165	CcSEcCtD
Methacholine—Cardiac arrest—Irinotecan—pancreatic cancer	0.00951	0.0146	CcSEcCtD
Methacholine—Cardiac arrest—Fluorouracil—pancreatic cancer	0.0091	0.014	CcSEcCtD
Methacholine—Bradycardia—Sunitinib—pancreatic cancer	0.00855	0.0131	CcSEcCtD
Methacholine—Lightheadedness—Docetaxel—pancreatic cancer	0.00852	0.0131	CcSEcCtD
Methacholine—Bronchospasm—Gemcitabine—pancreatic cancer	0.00828	0.0127	CcSEcCtD
Methacholine—Syncope—Erlotinib—pancreatic cancer	0.00757	0.0116	CcSEcCtD
Methacholine—Cough—Tamoxifen—pancreatic cancer	0.00745	0.0114	CcSEcCtD
Methacholine—Loss of consciousness—Erlotinib—pancreatic cancer	0.00742	0.0114	CcSEcCtD
Methacholine—Cough—Erlotinib—pancreatic cancer	0.00737	0.0113	CcSEcCtD
Methacholine—Chest pain—Tamoxifen—pancreatic cancer	0.00726	0.0112	CcSEcCtD
Methacholine—Chest pain—Erlotinib—pancreatic cancer	0.00719	0.011	CcSEcCtD
Methacholine—Bradycardia—Irinotecan—pancreatic cancer	0.00704	0.0108	CcSEcCtD
Methacholine—Shock—Erlotinib—pancreatic cancer	0.00678	0.0104	CcSEcCtD
Methacholine—Cough—Sunitinib—pancreatic cancer	0.00638	0.0098	CcSEcCtD
Methacholine—Chest pain—Sunitinib—pancreatic cancer	0.00622	0.00956	CcSEcCtD
Methacholine—Bronchospasm—Docetaxel—pancreatic cancer	0.00587	0.00902	CcSEcCtD
Methacholine—Shock—Sunitinib—pancreatic cancer	0.00587	0.00901	CcSEcCtD
Methacholine—Syncope—Irinotecan—pancreatic cancer	0.0054	0.00829	CcSEcCtD
Methacholine—Loss of consciousness—Irinotecan—pancreatic cancer	0.00529	0.00813	CcSEcCtD
Methacholine—Cough—Irinotecan—pancreatic cancer	0.00525	0.00807	CcSEcCtD
Methacholine—Cough—Gemcitabine—pancreatic cancer	0.00512	0.00786	CcSEcCtD
Methacholine—Chest pain—Gemcitabine—pancreatic cancer	0.00499	0.00767	CcSEcCtD
Methacholine—Pruritus—Tamoxifen—pancreatic cancer	0.00493	0.00757	CcSEcCtD
Methacholine—Chest pain—Fluorouracil—pancreatic cancer	0.00491	0.00754	CcSEcCtD
Methacholine—Pruritus—Erlotinib—pancreatic cancer	0.00487	0.00749	CcSEcCtD
Methacholine—Shock—Irinotecan—pancreatic cancer	0.00483	0.00743	CcSEcCtD
Methacholine—Dizziness—Tamoxifen—pancreatic cancer	0.00461	0.00707	CcSEcCtD
Methacholine—Hypotension—Irinotecan—pancreatic cancer	0.00459	0.00705	CcSEcCtD
Methacholine—Dizziness—Erlotinib—pancreatic cancer	0.00456	0.007	CcSEcCtD
Methacholine—Hypotension—Gemcitabine—pancreatic cancer	0.00447	0.00687	CcSEcCtD
Methacholine—Cardiac arrest—Epirubicin—pancreatic cancer	0.00443	0.00681	CcSEcCtD
Methacholine—Vomiting—Tamoxifen—pancreatic cancer	0.00443	0.0068	CcSEcCtD
Methacholine—Hypotension—Fluorouracil—pancreatic cancer	0.0044	0.00675	CcSEcCtD
Methacholine—Vomiting—Erlotinib—pancreatic cancer	0.00438	0.00673	CcSEcCtD
Methacholine—Headache—Tamoxifen—pancreatic cancer	0.00436	0.0067	CcSEcCtD
Methacholine—Headache—Erlotinib—pancreatic cancer	0.00432	0.00663	CcSEcCtD
Methacholine—Pruritus—Sunitinib—pancreatic cancer	0.00422	0.00648	CcSEcCtD
Methacholine—Nausea—Tamoxifen—pancreatic cancer	0.00414	0.00635	CcSEcCtD
Methacholine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.0041	0.0063	CcSEcCtD
Methacholine—Nausea—Erlotinib—pancreatic cancer	0.00409	0.00629	CcSEcCtD
Methacholine—Dizziness—Sunitinib—pancreatic cancer	0.00394	0.00606	CcSEcCtD
Methacholine—Vomiting—Sunitinib—pancreatic cancer	0.00379	0.00583	CcSEcCtD
Methacholine—Headache—Sunitinib—pancreatic cancer	0.00374	0.00574	CcSEcCtD
Methacholine—Syncope—Docetaxel—pancreatic cancer	0.00373	0.00573	CcSEcCtD
Methacholine—Loss of consciousness—Docetaxel—pancreatic cancer	0.00366	0.00562	CcSEcCtD
Methacholine—Cough—Docetaxel—pancreatic cancer	0.00363	0.00558	CcSEcCtD
Methacholine—Chest pain—Docetaxel—pancreatic cancer	0.00354	0.00544	CcSEcCtD
Methacholine—Nausea—Sunitinib—pancreatic cancer	0.00354	0.00544	CcSEcCtD
Methacholine—Pruritus—Gemcitabine—pancreatic cancer	0.00339	0.0052	CcSEcCtD
Methacholine—Shock—Docetaxel—pancreatic cancer	0.00334	0.00513	CcSEcCtD
Methacholine—Pruritus—Fluorouracil—pancreatic cancer	0.00333	0.00511	CcSEcCtD
Methacholine—Bradycardia—Epirubicin—pancreatic cancer	0.00328	0.00504	CcSEcCtD
Methacholine—Dizziness—Irinotecan—pancreatic cancer	0.00325	0.00499	CcSEcCtD
Methacholine—Hypotension—Docetaxel—pancreatic cancer	0.00317	0.00488	CcSEcCtD
Methacholine—Vomiting—Irinotecan—pancreatic cancer	0.00312	0.0048	CcSEcCtD
Methacholine—Dizziness—Fluorouracil—pancreatic cancer	0.00311	0.00478	CcSEcCtD
Methacholine—Headache—Irinotecan—pancreatic cancer	0.00308	0.00473	CcSEcCtD
Methacholine—Vomiting—Gemcitabine—pancreatic cancer	0.00304	0.00467	CcSEcCtD
Methacholine—Bradycardia—Doxorubicin—pancreatic cancer	0.00304	0.00467	CcSEcCtD
Methacholine—Headache—Gemcitabine—pancreatic cancer	0.003	0.00461	CcSEcCtD
Methacholine—Vomiting—Fluorouracil—pancreatic cancer	0.00299	0.0046	CcSEcCtD
Methacholine—Headache—Fluorouracil—pancreatic cancer	0.00295	0.00453	CcSEcCtD
Methacholine—Nausea—Irinotecan—pancreatic cancer	0.00292	0.00448	CcSEcCtD
Methacholine—Nausea—Gemcitabine—pancreatic cancer	0.00284	0.00437	CcSEcCtD
Methacholine—Nausea—Fluorouracil—pancreatic cancer	0.0028	0.00429	CcSEcCtD
Methacholine—Syncope—Epirubicin—pancreatic cancer	0.00252	0.00387	CcSEcCtD
Methacholine—Loss of consciousness—Epirubicin—pancreatic cancer	0.00247	0.00379	CcSEcCtD
Methacholine—Cough—Epirubicin—pancreatic cancer	0.00245	0.00376	CcSEcCtD
Methacholine—Pruritus—Docetaxel—pancreatic cancer	0.0024	0.00369	CcSEcCtD
Methacholine—Chest pain—Epirubicin—pancreatic cancer	0.00239	0.00367	CcSEcCtD
Methacholine—Syncope—Doxorubicin—pancreatic cancer	0.00233	0.00358	CcSEcCtD
Methacholine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00228	0.00351	CcSEcCtD
Methacholine—Cough—Doxorubicin—pancreatic cancer	0.00227	0.00348	CcSEcCtD
Methacholine—Shock—Epirubicin—pancreatic cancer	0.00225	0.00346	CcSEcCtD
Methacholine—Dizziness—Docetaxel—pancreatic cancer	0.00225	0.00345	CcSEcCtD
Methacholine—Chest pain—Doxorubicin—pancreatic cancer	0.00221	0.0034	CcSEcCtD
Methacholine—Vomiting—Docetaxel—pancreatic cancer	0.00216	0.00332	CcSEcCtD
Methacholine—Hypotension—Epirubicin—pancreatic cancer	0.00214	0.00329	CcSEcCtD
Methacholine—Headache—Docetaxel—pancreatic cancer	0.00213	0.00327	CcSEcCtD
Methacholine—Shock—Doxorubicin—pancreatic cancer	0.00209	0.0032	CcSEcCtD
Methacholine—Nausea—Docetaxel—pancreatic cancer	0.00202	0.0031	CcSEcCtD
Methacholine—Hypotension—Doxorubicin—pancreatic cancer	0.00198	0.00304	CcSEcCtD
Methacholine—Pruritus—Epirubicin—pancreatic cancer	0.00162	0.00249	CcSEcCtD
Methacholine—Dizziness—Epirubicin—pancreatic cancer	0.00151	0.00233	CcSEcCtD
Methacholine—Pruritus—Doxorubicin—pancreatic cancer	0.0015	0.0023	CcSEcCtD
Methacholine—Vomiting—Epirubicin—pancreatic cancer	0.00146	0.00224	CcSEcCtD
Methacholine—Headache—Epirubicin—pancreatic cancer	0.00144	0.0022	CcSEcCtD
Methacholine—Dizziness—Doxorubicin—pancreatic cancer	0.0014	0.00215	CcSEcCtD
Methacholine—Nausea—Epirubicin—pancreatic cancer	0.00136	0.00209	CcSEcCtD
Methacholine—Vomiting—Doxorubicin—pancreatic cancer	0.00135	0.00207	CcSEcCtD
Methacholine—Headache—Doxorubicin—pancreatic cancer	0.00133	0.00204	CcSEcCtD
Methacholine—Nausea—Doxorubicin—pancreatic cancer	0.00126	0.00193	CcSEcCtD
Methacholine—CHRM3—GPCR downstream signaling—CCK—pancreatic cancer	0.000632	0.00181	CbGpPWpGaD
Methacholine—CHRM3—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	0.00063	0.0018	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GAST—pancreatic cancer	0.000628	0.0018	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CCK—pancreatic cancer	0.000626	0.00179	CbGpPWpGaD
Methacholine—CHRM2—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	0.000624	0.00179	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—CNR2—pancreatic cancer	0.000616	0.00176	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000616	0.00176	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00061	0.00175	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CNR2—pancreatic cancer	0.00061	0.00175	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000609	0.00174	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000606	0.00174	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—SCT—pancreatic cancer	0.000601	0.00172	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.0006	0.00172	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—SCT—pancreatic cancer	0.000596	0.00171	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRLHR—pancreatic cancer	0.000575	0.00165	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CCK—pancreatic cancer	0.000574	0.00164	CbGpPWpGaD
Methacholine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	0.000574	0.00164	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRLHR—pancreatic cancer	0.000569	0.00163	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CCK—pancreatic cancer	0.000568	0.00163	CbGpPWpGaD
Methacholine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	0.000568	0.00163	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ARG2—pancreatic cancer	0.000561	0.00161	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CNR2—pancreatic cancer	0.000559	0.0016	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GLP1R—pancreatic cancer	0.000559	0.0016	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CNR2—pancreatic cancer	0.000554	0.00159	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000554	0.00159	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CCKAR—pancreatic cancer	0.00055	0.00158	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—IAPP—pancreatic cancer	0.000545	0.00156	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000545	0.00156	CbGpPWpGaD
Methacholine—CHRM3—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	0.000542	0.00155	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ACVR1B—pancreatic cancer	0.000541	0.00155	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ZNRF3—pancreatic cancer	0.000541	0.00155	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—IAPP—pancreatic cancer	0.00054	0.00155	CbGpPWpGaD
Methacholine—CHRM2—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.00054	0.00155	CbGpPWpGaD
Methacholine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	0.000537	0.00154	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000535	0.00153	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000535	0.00153	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000523	0.0015	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000522	0.00149	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000518	0.00149	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—SHH—pancreatic cancer	0.000501	0.00144	CbGpPWpGaD
Methacholine—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	0.000498	0.00143	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—SHH—pancreatic cancer	0.000497	0.00142	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IAPP—pancreatic cancer	0.000495	0.00142	CbGpPWpGaD
Methacholine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	0.000493	0.00141	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IAPP—pancreatic cancer	0.00049	0.00141	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—TYMP—pancreatic cancer	0.00049	0.0014	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SSTR3—pancreatic cancer	0.000489	0.0014	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—DTX1—pancreatic cancer	0.000489	0.0014	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—DTX1—pancreatic cancer	0.000484	0.00139	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SSTR3—pancreatic cancer	0.000484	0.00139	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—SST—pancreatic cancer	0.000479	0.00137	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PTHLH—pancreatic cancer	0.000475	0.00136	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PTCH1—pancreatic cancer	0.000475	0.00136	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—SST—pancreatic cancer	0.000474	0.00136	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000471	0.00135	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000471	0.00135	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.00047	0.00135	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SSTR1—pancreatic cancer	0.000469	0.00134	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SSTR1—pancreatic cancer	0.000464	0.00133	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PPY—pancreatic cancer	0.00046	0.00132	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PPY—pancreatic cancer	0.000455	0.0013	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SSTR2—pancreatic cancer	0.000451	0.00129	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SSTR2—pancreatic cancer	0.000447	0.00128	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—CNR1—pancreatic cancer	0.000442	0.00127	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000438	0.00125	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCKBR—pancreatic cancer	0.000436	0.00125	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—SST—pancreatic cancer	0.000435	0.00125	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000433	0.00124	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCKBR—pancreatic cancer	0.000432	0.00124	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—SST—pancreatic cancer	0.000431	0.00123	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000429	0.00123	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000428	0.00123	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—GCG—pancreatic cancer	0.000427	0.00122	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—GCG—pancreatic cancer	0.000423	0.00121	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000415	0.00119	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GLI1—pancreatic cancer	0.00041	0.00117	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—DTX4—pancreatic cancer	0.00041	0.00117	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000407	0.00117	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—DTX4—pancreatic cancer	0.000406	0.00116	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GLI1—pancreatic cancer	0.000406	0.00116	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000404	0.00116	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000403	0.00116	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CNR1—pancreatic cancer	0.000401	0.00115	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NRP1—pancreatic cancer	0.000399	0.00114	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000399	0.00114	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CNR1—pancreatic cancer	0.000397	0.00114	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GLP1R—pancreatic cancer	0.000395	0.00113	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000395	0.00113	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NRP1—pancreatic cancer	0.000395	0.00113	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—DPYD—pancreatic cancer	0.000389	0.00111	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GCG—pancreatic cancer	0.000388	0.00111	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GCG—pancreatic cancer	0.000384	0.0011	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HEY2—pancreatic cancer	0.000384	0.0011	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HEY2—pancreatic cancer	0.00038	0.00109	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GAST—pancreatic cancer	0.000375	0.00107	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000371	0.00106	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GAST—pancreatic cancer	0.000371	0.00106	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AGTR1—pancreatic cancer	0.00037	0.00106	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SLC2A2—pancreatic cancer	0.000369	0.00106	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000366	0.00105	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SCT—pancreatic cancer	0.000355	0.00102	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HEY1—pancreatic cancer	0.000355	0.00102	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SCT—pancreatic cancer	0.000352	0.00101	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HEY1—pancreatic cancer	0.000352	0.00101	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000344	0.000984	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCK—pancreatic cancer	0.000339	0.000971	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCK—pancreatic cancer	0.000336	0.000962	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CNR2—pancreatic cancer	0.00033	0.000946	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GLP1R—pancreatic cancer	0.00033	0.000946	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—CXCL8—pancreatic cancer	0.00033	0.000946	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	0.000327	0.000937	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	0.000327	0.000937	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000327	0.000937	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCKAR—pancreatic cancer	0.000325	0.000931	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	0.000322	0.000922	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—JAG2—pancreatic cancer	0.000315	0.000903	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	0.000312	0.000894	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MEN1—pancreatic cancer	0.000311	0.00089	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	0.000307	0.000881	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SHH—pancreatic cancer	0.000296	0.000849	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOTCH4—pancreatic cancer	0.000294	0.000843	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SHH—pancreatic cancer	0.000293	0.000841	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IAPP—pancreatic cancer	0.000293	0.000838	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000292	0.000835	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	0.00029	0.00083	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CD44—pancreatic cancer	0.000286	0.000818	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTHLH—pancreatic cancer	0.000281	0.000805	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTCH1—pancreatic cancer	0.000281	0.000805	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	0.000278	0.000797	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	0.000278	0.000797	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GCG—pancreatic cancer	0.000274	0.000784	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—STK11—pancreatic cancer	0.000257	0.000738	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SST—pancreatic cancer	0.000257	0.000736	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SST—pancreatic cancer	0.000254	0.000729	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000253	0.000726	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	0.000251	0.00072	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000251	0.000719	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	0.00025	0.000717	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	0.000249	0.000713	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000248	0.00071	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	0.000237	0.000679	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	0.000235	0.000673	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	0.00023	0.000659	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GCG—pancreatic cancer	0.000229	0.000656	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000228	0.000653	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GCG—pancreatic cancer	0.000227	0.00065	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000223	0.000638	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—TYMS—pancreatic cancer	0.000221	0.000634	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000221	0.000632	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	0.000218	0.000626	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	0.000216	0.00062	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—STK11—pancreatic cancer	0.000215	0.000617	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—STK11—pancreatic cancer	0.000213	0.000611	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000202	0.000579	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.0002	0.000574	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000194	0.000556	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000192	0.000551	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	0.000189	0.00054	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	0.000187	0.000535	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000187	0.000534	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000185	0.000529	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HES1—pancreatic cancer	0.000184	0.000527	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HES1—pancreatic cancer	0.000182	0.000522	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOE—pancreatic cancer	0.00018	0.000516	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000176	0.000505	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000175	0.0005	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	0.000169	0.000485	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000168	0.000481	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CG—pancreatic cancer	0.000163	0.000466	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TERT—pancreatic cancer	0.000161	0.000462	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TERT—pancreatic cancer	0.00016	0.000458	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPARG—pancreatic cancer	0.000157	0.000449	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	0.000154	0.000442	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	0.000154	0.000441	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	0.000153	0.000438	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	0.000152	0.000437	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOE—pancreatic cancer	0.000151	0.000431	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOE—pancreatic cancer	0.000149	0.000427	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KDR—pancreatic cancer	0.000148	0.000423	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KDR—pancreatic cancer	0.000146	0.000419	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CD—pancreatic cancer	0.000143	0.000409	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	0.00014	0.000402	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	0.000139	0.000398	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000139	0.000398	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000138	0.000394	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	0.000136	0.000389	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	0.000136	0.000389	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000135	0.000386	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	0.000135	0.000386	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EGF—pancreatic cancer	0.000134	0.000385	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	0.000133	0.000381	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CB—pancreatic cancer	0.000125	0.000357	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	0.000124	0.000355	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PTGS2—pancreatic cancer	0.000123	0.000354	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	0.000123	0.000351	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	0.000119	0.000342	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000118	0.000339	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000118	0.000339	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000117	0.000336	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	0.000117	0.000335	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	0.000116	0.000332	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PTEN—pancreatic cancer	0.000108	0.000308	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000107	0.000308	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000106	0.000305	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	0.000104	0.000298	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	0.000103	0.000295	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	0.0001	0.000287	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	9.94e-05	0.000285	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	9.91e-05	0.000284	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	9.84e-05	0.000282	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	9.67e-05	0.000277	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	9.58e-05	0.000274	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	9.57e-05	0.000274	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	9.48e-05	0.000272	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	9.32e-05	0.000267	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	9.23e-05	0.000265	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	9.23e-05	0.000265	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	9.14e-05	0.000262	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	9.05e-05	0.000259	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	9e-05	0.000258	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	8.96e-05	0.000257	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	8.91e-05	0.000255	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	8.78e-05	0.000252	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	8.69e-05	0.000249	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	8.34e-05	0.000239	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	8.26e-05	0.000237	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	8.13e-05	0.000233	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	8.05e-05	0.000231	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	8.05e-05	0.000231	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	8.03e-05	0.00023	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	7.97e-05	0.000228	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	7.95e-05	0.000228	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	7.59e-05	0.000218	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	7.48e-05	0.000214	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	7.46e-05	0.000214	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	7.4e-05	0.000212	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	7.39e-05	0.000212	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	7.31e-05	0.00021	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	7.24e-05	0.000208	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	6.91e-05	0.000198	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	6.84e-05	0.000196	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	6.35e-05	0.000182	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	6.29e-05	0.00018	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AKT1—pancreatic cancer	6.2e-05	0.000178	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	6.14e-05	0.000176	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	6.08e-05	0.000174	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	5.87e-05	0.000168	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	5.82e-05	0.000167	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	5.19e-05	0.000149	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	5.14e-05	0.000147	CbGpPWpGaD
